Table 2.

ATM mutations in the 155 patients in the CLL cohort


Tumor ID

Sequence change

Protein change

Present in diagnostic sample

ATM function

IGVH mutation status and family

TFS, mo

OS, mo

Refractory to Flu/Chl
Tumors with 2 mutant ATM alleles         
   77*  1058DelGT   Truncated protein   Yes   Defective   99%, VH1-2   0   83  Yes  
   77*  5224G/C   A1742P   Yes   Defective   99%, VH1-2   0   83  Yes  
   96*  2929Ins9   Inframe insertion   Yes   Defective   96%, VH4-61   33   79   Yes  
   96*  5041A/G   I1681V   Yes   Defective   96%, VH4-61   33   79   Yes  
   96*  5044G/T   D1682Y   Yes   Defective   96%, VH4-61   33   79   Yes  
   11*  5821G/C   V1941L   Not known   Defective   98%, VH3-15   108   156  Yes  
   11*  7313C/A   T2438K   Not known   Defective   98%, VH3-15   108   156  Yes  
   11*  8833Del34   Truncated protein   Not known   Defective   98%, VH3-15   108   156  Yes  
Tumors with 1 mutant ATM allele and loss of the second allele         
   57*  2308G/T   Truncated protein   Not known   Partial defect   97%, VH4-59   76   101  No  
   15*  7047C/G   C2349W   Not known   Defective   100%, VH1-69   40   75   Yes  
   07*  8600G/A   G2867E   Yes   Defective   99%, VH3-11   0   96   Yes  
   152*  8839A/T   T2946S   At 1 year§  Defective   99%, VH1-6   35   79  No  
Tumors with 1 mutant ATM allele and 1 wild-type ATM allele         
   75   1009C/A   R337S   Yes   Defective   98%, VH3-30   0   39   Yes  
   69   6815DelA   Truncated protein   Not known   Defective   100%, VH3-15   39   72  No  
   119   9022C/T   R3008C   Not known   Defective   97%, VH3-64   36   47  No  
   93   5290del C   Truncated protein   Yes   Defective   100%, VH5-51   26  26  NT  
   92   5980A/G   K1994E   Yes   Partial defect   99%, VH1-69   24  24   NT  
   124  5228C/T   T1743I   Not known   Partial defect   85%, VH3-15   48  48  NT  
   84  5821G/C   V1941L   Yes   Partial defect   93%, VH3-7   14   17   Yes  
   27   3383A/G   Q1127R   Not known   Normal   99%, VH3-21   0   77   Yes  
   113   3964C/A   L1322F   Not known   Normal   91%, VH3-7   24  24   NT  
   147   IVS16-10T/G   Exon skip   Not known   Not done   94%, VH5-51   NA   NA   NA  
   81
 
5882A/G
 
Y1961C
 
Not known
 
Not done
 
93%, VH3-15
 
36
 
36
 
NT
 

Tumor ID

Sequence change

Protein change

Present in diagnostic sample

ATM function

IGVH mutation status and family

TFS, mo

OS, mo

Refractory to Flu/Chl
Tumors with 2 mutant ATM alleles         
   77*  1058DelGT   Truncated protein   Yes   Defective   99%, VH1-2   0   83  Yes  
   77*  5224G/C   A1742P   Yes   Defective   99%, VH1-2   0   83  Yes  
   96*  2929Ins9   Inframe insertion   Yes   Defective   96%, VH4-61   33   79   Yes  
   96*  5041A/G   I1681V   Yes   Defective   96%, VH4-61   33   79   Yes  
   96*  5044G/T   D1682Y   Yes   Defective   96%, VH4-61   33   79   Yes  
   11*  5821G/C   V1941L   Not known   Defective   98%, VH3-15   108   156  Yes  
   11*  7313C/A   T2438K   Not known   Defective   98%, VH3-15   108   156  Yes  
   11*  8833Del34   Truncated protein   Not known   Defective   98%, VH3-15   108   156  Yes  
Tumors with 1 mutant ATM allele and loss of the second allele         
   57*  2308G/T   Truncated protein   Not known   Partial defect   97%, VH4-59   76   101  No  
   15*  7047C/G   C2349W   Not known   Defective   100%, VH1-69   40   75   Yes  
   07*  8600G/A   G2867E   Yes   Defective   99%, VH3-11   0   96   Yes  
   152*  8839A/T   T2946S   At 1 year§  Defective   99%, VH1-6   35   79  No  
Tumors with 1 mutant ATM allele and 1 wild-type ATM allele         
   75   1009C/A   R337S   Yes   Defective   98%, VH3-30   0   39   Yes  
   69   6815DelA   Truncated protein   Not known   Defective   100%, VH3-15   39   72  No  
   119   9022C/T   R3008C   Not known   Defective   97%, VH3-64   36   47  No  
   93   5290del C   Truncated protein   Yes   Defective   100%, VH5-51   26  26  NT  
   92   5980A/G   K1994E   Yes   Partial defect   99%, VH1-69   24  24   NT  
   124  5228C/T   T1743I   Not known   Partial defect   85%, VH3-15   48  48  NT  
   84  5821G/C   V1941L   Yes   Partial defect   93%, VH3-7   14   17   Yes  
   27   3383A/G   Q1127R   Not known   Normal   99%, VH3-21   0   77   Yes  
   113   3964C/A   L1322F   Not known   Normal   91%, VH3-7   24  24   NT  
   147   IVS16-10T/G   Exon skip   Not known   Not done   94%, VH5-51   NA   NA   NA  
   81
 
5882A/G
 
Y1961C
 
Not known
 
Not done
 
93%, VH3-15
 
36
 
36
 
NT
 

Flu indicates fludarabine; Chl, chlorambucil; OS, overall survival; TFS, treatment-free survival; ND, not done; NT, not treated; NA, not available.

*

Patients with predicted loss of both functional ATM alleles

Treatment or death, respectively, has not occurred

Patients with ATM and TP53 mutations

§

See “ATM mutations are present early in disease ontogenesis and usually at diagnosis”

or Create an Account

Close Modal
Close Modal